HIV/AIDS and Infectious Disease

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Alissa Kanowitz, Founding Member Families Fighting Flu Mrs. Alissa Kanowitz became a patient advocate after experiencing the absolute worst-case scenario: losing her four-year-old daughter Amanda to the flu. And now, she’s here with Dr. Mary Katherine Cheeley to share her and Amanda’s story as well as her experience working with the Families Fighting Flu organization. This is so we can all better understand the

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: David Hamer, MD Cases of chikungunya have risen significantly in recent years, but fortunately, there are several ways we can protect our patients traveling abroad, including with a novel vaccine and other anti-mosquito measures. Joining Dr. Charles Tuck to discuss key preventive strategies for the chikungunya virus is Dr. David Hamer, Professor of Global Health and Medicine at the Boston University School of Public Health.

Host: Jody Takemoto, PhD Guest: Robert Wong, MD Hepatitis B is one of the leading causes of liver cancer globally, underscoring the importance of screening, diagnosing, and treating patients appropriately. However, there are several considerations to keep in mind when caring for patients with hepatocellular carcinoma with hepatitis B co-infection, which is why Dr. Jody Takemoto speaks with Dr. Robert Wong about those factors and essential management strategies. Dr. Wong is a

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jill Foster, MD For optimal protection, the best time for patients to receive a flu shot is between September and October, but some patients may be hesitant. In fact, flu vaccination rates have been declining since the onset of the COVID-19 pandemic according to the CDC. That’s why Dr. Charles Turck speaks with Dr. Jill Foster about how we can help ensure patients receive timely and annual flu vaccinations. Dr. Foster is the Director

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Christina Madison, BS, PharmD, BCACP, AAHIVP The World Health Organization and the Vaccines and Related Biologics Products Advisory Committee recently recommended transitioning from quadrivalent to trivalent flu vaccines that exclude the B/Yamagata lineage. Explore the epidemiological data that led to this decision and counseling strategies that can help patients understand this new recommendation with Dr. Charles Turck and Dr

Guest: Darvin Scott Smith, MD For optimal protection, the most prevalent flu strains are assessed every year and included in the vaccine. Here to talk about this process and the recent decision to exclude the B/Yamagata lineage from flu vaccines is Dr. Darvin Scott Smith, Infectious Disease and Geographic Medicine Consultant at San Mateo Medical Center in California.

Host: Jennifer Shu, MD, FAAP The MMR vaccine offers protection from measles, mumps, and rubella, but why is it so important for children in particular to receive this vaccine? What are the proper doses for our patients who need protection, and who doesn’t need the MMR vaccine? These are just some of the FAQs Dr. Jennifer Shu answers amid our country’s measles outbreak.